Click here to view the United Healthcare (UHC) Medical Policy Updates » December 2024 United…
BCBS Florida Medical Policy Updates – July 2021
Click here to view the Blue Cross Blue Shield BCBS Florida Medical Policy Updates »
July 2021 BCBS Florida Medical Policy Updates:
- Aducanumab-avwa (Aduhelm™)
- Analysis of Human DNA as a Technique for Colorectal Cancer Screening
- Apheresis, Plasmapheresis and Plasma Exchange
- Belantamab Mafodotin-blmf (Blenrep ) IV Infusion
- Bevacizumab (Avastin®), bevacizumab-awwb (Mvasi), and bevacizumab-bvzr (Zirabev) Injection
- Bortezomib Injection
- Botulinum Toxins
- Cannabidiol (Epidiolex®)
- Carfilzomib (Kyprolis) Injection
- Chimeric Antigen Receptor (CAR) T-Cell
- Chimeric Antigen Receptor (CAR) T-Cell
- Computer-Assisted Navigation for Orthopedic Procedures
- Cooling and Heating Devices Used in the Outpatient Setting
- Crizanlizumab-tcma (Adakveo)
- Daratumumab (Darzalex ) Infusion and Daratumumab-Hyaluronidase-fihj (Darzalex Faspro ) Injection
- Denosumab (Prolia™; Xgeva™) Injection
- Elexacaftor-tezacaftor-ivacaftor (Trikafta)
- Elotuzumab (Empliciti ) Injection
- Evinacumab-dgnb (Evkeeza ) IV Infusion
- Evoked Potentials, Intraoperative Neurophysiologic Monitoring, and Quantitative Electroencephalography (QEEG)
- Exon-Skipping Therapy for Duchenne Muscular Dystrophy
- Extracorporeal Membrane Oxygenation (ECMO) for Adult Conditions
- Gonadotropin Releasing Hormone Analogs and Antagonists
- Granulocyte Colony Stimulating Factors
- Hormone Replacement
- Infliximab Products
- Investigational Services
- Isatuximab-irfc (Sarclisa®) Infusion
- Ixazomib (Ninlaro ) Capsule
- Laboratory Tests Post Transplant and for Heart Failure
- Lanreotide (Somatuline® Depot) Injection
- Lumasiran (Oxlumo) injection
- Margetuximab-cmkb (Margenza )
- Melphalan Flufenamide (Pepaxto ) IV infusion
- Melphalan Flufenamide (Pepaxto ) IV infusion
- Minimally Invasive Procedures for the Treatment of Gastroesophageal Reflux Disease (GERD) and Dysphagia
- Nab-Paclitaxel Injection (Abraxane)
- Naxitamab-gqgk (Danyelza) Injection
- NK-1 receptor antagonist injectable therapy (Emend®, Cinvanti®)
- Obeticholic Acid (Ocaliva ) Tablet
- Octreotide Acetate (Sandostatin LAR Depot, Bynfezia Pen™, Mycapssa Capsule)
- Omadacycline (Nuzyra ) Tablets
- Oral Oncology Medications
- Osilodrostat (Isturisa) tablets
- Palivizumab (Synagis®)
- Pasireotide (Signifor®, Signifor LAR®) Injection
- Peanut (Arachis hypogaea) Allergen Powder- dnfd (Palforzia)
- Pegvaliase-pqpz (Palynziq)
- Percutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation
- Pitolisant (Wakix)
- Ponesimod (Ponvory™) Tablet
- Positive Pressure Ventilation
- Positron Emission Tomography (PET) for Oncologic Applications
- Preventive Services
- Preventive Services
- Prosthetic Eyes and Lens Implants
- Ravulizumab (Ultomiris™) IV
- Risankizumab-rzaa (Skyrizi) Injection
- Rituximab Products
- SARS-CoV-2 Monoclonal Antibodies
- Secukinumab (Cosentyx ) Injection
- Tezacaftor/Ivacaftor (Symdeko)
- Total Body Plethysmography
- Transcatheter Mitral Valve Repair (TMVR)
- Treatments for Varicose Veins/Venous Insufficiency
- Trilaciclib (Cosela) IV infusion
- Tumor Treating Fields Therapy
- Tumor/Genetic Markers
- Ultrasound Osteogenesis Stimulators, Non-Invasive
- Viscocanalostomy and Canaloplasty
- Voclosporin (Lupkynis)
- Voxelotor (Oxbryta™)
Click here to view the Blue Cross Blue Shield BCBS Florida Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
